Latest News and Press Releases

– Less than 1 in 10 were on any non-statin lipid lowering therapy – – Findings were shared at the National Lipid Association Scientific Sessions – ANN ARBOR, Mich., June 03, 2022 (GLOBE...

– Highlight of accepted abstracts includes new real-world data on lipid-lowering therapy usage, submitted in partnership with UT Southwestern – – Accepted abstracts showcase breadth of Esperion’s...

JACKSONVILLE, Fla. and ORANGEBURG, N.Y., March 02, 2021 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA), the preeminent global authority on lipid disorders, and Paradigm Medical...

JACKSONVILLE, Fla., July 10, 2020 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) today announced the release of its official scientific statement on the use of genetic testing in the...

MIAMI, May 18, 2019 (GLOBE NEWSWIRE) -- Robert S. Rosenson, MD, FACC, FACP, FAHA, FESC, FNLA, FACCP, Professor of Medicine and Director of Cardiometabolic Disorders at the Icahn School of Medicine...

MIAMI, May 18, 2019 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) and the Foundation of the NLA have selected Vera A. Bittner, MD, MSPH, FNLA as the recipient of the 2019 W. Virgil Brown...

MIAMI, Fla., May 17, 2019 (GLOBE NEWSWIRE) -- With the Centers for Disease Control and Prevention (CDC) indicating more than 95 million adults age 20 or older have total cholesterol (blood fat)...

MIAMI, May 17, 2019 (GLOBE NEWSWIRE) -- Findings of the first patient statin use survey based on a comprehensive set of patient experiences and behavioral markers were presented today at the...

JACKSONVILLE, Fla., May 17, 2019 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) today announced the release of an official scientific statement on Lipoprotein(a) [Lp(a)] clinical use at...

SOUTH PLAINFIELD, N.J., May 23, 2017 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company developing comprehensive genetic tests for risk assessment and early diagnosis of...